These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2029804)

  • 21. [Lower limb edema during valpromide treatment: case report and literature review].
    Gabriel L; Darcissac C; Goutelle S; Sève P; Vial T; de La Gastine B
    Rev Med Interne; 2015 Oct; 36(10):698-700. PubMed ID: 25544148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of valpromide and viloxazine on the elimination of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Perucca E; Pisani F; Spina E; Oteri G; Fazio A; Bertilsson L
    Pharmacol Res; 1989; 21(1):111-2. PubMed ID: 2498859
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain.
    Winkler I; Blotnik S; Shimshoni J; Yagen B; Devor M; Bialer M
    Br J Pharmacol; 2005 Sep; 146(2):198-208. PubMed ID: 15997234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity.
    Haj-Yehia A; Bialer M
    Pharm Res; 1989 Aug; 6(8):683-9. PubMed ID: 2510141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic analysis of the structural requirements for forming "stable" analogues of valpromide.
    Haj-Yehia A; Hadad S; Bialer M
    Pharm Res; 1992 Aug; 9(8):1058-63. PubMed ID: 1409378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.
    Eadie MJ
    Clin Pharmacokinet; 1991 Jul; 21(1):27-41. PubMed ID: 1914340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
    Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid.
    Hadad S; Vree TB; van der Kleijn E; Bialer M
    Biopharm Drug Dispos; 1993 Jan; 14(1):51-9. PubMed ID: 8427944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed and prolonged coma following valpromide poisoning in a 4-year-old girl.
    Boels D; Mégarbane B; Bouquié R
    Clin Toxicol (Phila); 2021 Aug; 59(8):763-764. PubMed ID: 33274655
    [No Abstract]   [Full Text] [Related]  

  • 31. Possible hazard of valpromide-carbamazepine combination therapy in epilepsy.
    Meijer JW; Binnie CD; Debets RM; van Parys JA; de Beer-Pawlikowski NK
    Lancet; 1984 Apr; 1(8380):802. PubMed ID: 6143129
    [No Abstract]   [Full Text] [Related]  

  • 32. The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers and antipsychotics.
    Janicak PG
    J Clin Psychiatry; 1993 Sep; 54 Suppl():35-41; discussion 55-6. PubMed ID: 8104932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of drug-drug interactions with carbamazepine-10,11-epoxide using a new in vitro assay for epoxide hydrolase inhibition.
    Rosa M; Bonnaillie P; Chanteux H
    Xenobiotica; 2016 Dec; 46(12):1076-1084. PubMed ID: 26936324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
    Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR
    Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of biological tags in a case of acute valpromide self poisoning].
    Commandeur D; Danguy Des Deserts M; Giacardi C; Eyrieux S; Ould-Ahmed M; Drouillard I
    Ann Biol Clin (Paris); 2010; 68(2):234-8. PubMed ID: 20348051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of antiepileptic drugs in elderly nursing home residents.
    Birnbaum AK
    Int Rev Neurobiol; 2007; 81():211-20. PubMed ID: 17433926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of two tetramethylcyclopropane analogues of valpromide in the brain, liver, plasma and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Eur J Pharm Sci; 1998 Apr; 6(2):93-8. PubMed ID: 9795021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
    Perucca E; Johannessen SI
    Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects.
    Pisani F; Fazio A; Artesi C; Oteri G; Spina E; Tomson T; Perucca E
    Br J Clin Pharmacol; 1992 Jul; 34(1):85-7. PubMed ID: 1352988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.